Outcome of the Board Meeting.
BLACKROSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Black Rose Industries reported its Q2 FY26 (ended 30 September 2025) standalone results with revenue from operations of ₹83.98 crore, down about 9.7% YoY from ₹93.05 crore. Net profit fell sharply to ₹4.43 crore from ₹10.27 crore in Q2 FY25, a ~57% decline, hurt by higher stock-in-trade purchases and sharply lower other income. For H1 FY26, revenue declined to ₹143.83 crore (vs ₹167.22 crore) and PAT to ₹8.67 crore (vs ₹14.95 crore). The auditor (M M Nissim & Co LLP) issued an unmodified (clean) limited review report on both standalone and consolidated results. The board also approved appointing Mr. Mayur Desai, a Chartered Accountant with 40+ years of experience in taxation and advisory, as an Additional Independent Director for 5 years, subject to shareholder approval via postal ballot. The wholly-owned Japan subsidiary B.R. Chemicals Co. Ltd. has been classified as discontinued operations as the board moves towards its closure/sale.
The double-digit fall in both revenue and profits on a YoY basis is a negative near-term signal and may weigh on stock sentiment, but the company remains profitable with a clean audit report, an improving balance sheet (operating cash flow swung positive to ₹20.5 crore in H1 from negative ₹12.1 crore in FY25) and stable equity base. Director induction strengthens governance, and the Japan subsidiary wind-down should help focus on the core profitable chemicals business.